• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
Ramakanta Biswas

Bhubaneswar: A day after Serum Institute of India reduced Covishield vaccine price for States to Rs 300 per dose as a philanthropic gesture, Bharat Biotech also slashed the price of Covaxin. The vaccine will now be available to State governments at a price of Rs 400 per dose.

“Bharat Biotech is deeply concerned with the critical pandemic circumstances that India is facing at this time. Recognising the enormous challenges to the public health care system, we have made Covaxin available to State Governments at a price of Rs.400/dose,” the vaccine maker said in a statement.

“We wish to be transparent in our approach to pricing which was determined by internally funded product development, several operationally-intensive BSL-3 manufacturing facilities the first of its kind in our country) and clinical Viols,” it added.

The vaccine manufacturer further said, “We wish to champion “Innovation in India” and our commitment to public health is absolute.”

For the last year Team Bharat Biotech has been fearlessly handling Live SARS-CoV-2 virus strains, tirelessly working round-the-clock while overcoming many challenges given the uncertainty of the pandemic.

With the greater part of the organization’s facilities and resources being diverted to COVID-19 vaccines, we continue to work towards offering superior COVID-1 9 vaccines and sincerely wish that this gesture enables our country towards a foster recovery.

We offer our prayers to all the citizens of India and wish them safety and health!

Other Stories